Published in Obesity and Diabetes Week, August 14th, 2006
"The pharmacokinetic and pharmacodynamic properties of biphasic insulin aspart (BIAsp 30) (30% soluble, 70% protaminated insulin aspart [IAsp]) and insulin glargine (IGlarg) were compared. Twelve people with type 2 diabetes took part in two 24-h isoglycemic clamp studies, 1 week apart," investigators in Wales report.
"Patients were randomized to treatment with 0.5 U/kg of BIAsp 30 (0.25 U/kg at 08.30 h and 0.25 U/kg...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week